Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
Home>Topics>>Centene (CNC) agrees to buy AcariaHealth from Enhanced Equity Funds for $152M, in a move that expands CNC's specialized pharmacy benefit services for such complex diseases as hepatitis C, hemophilia, ...

Centene (CNC) agrees to buy AcariaHealth from Enhanced Equity Funds for $152M, in a move that expands CNC's specialized pharmacy benefit services for such complex diseases as hepatitis C, hemophilia, ...

SeekingAlpha.com: SA Currents

Mon, 14 Jan 2013

Centene ( CNC ) agrees to buy AcariaHealth from Enhanced Equity Funds for $152M, in a move that expands CNC's specialized pharmacy benefit services for such complex diseases as hepatitis C, hemophilia, multiple sclerosis, rheumatoid arthritis and oncology. Post your comment!

Read the rest of this article on SeekingAlpha.com: SA Currents

Related Topics:

  1. Centene
Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.